MDx Startup Xagenic Closes on $10M Series A Financing Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics startup Xagenic today announced the closing of a Series A financing round that raised C$10 million (US$10 million).

CTI Life Sciences Fund and the Ontario Emerging Technologies Fund led the round, with "significant participation" by Qiagen, Toronto-based Xagenic said. The money will go toward the development of a decentralized molecular diagnostic platform for use in doctors' offices, clinics, and hospital systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.